These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6343980)

  • 21. Outbreak of Serratia marcescens Coproducing ArmA and CTX-M-15 Mediated High Levels of Resistance to Aminoglycoside and Extended-Spectrum Beta-Lactamases, Algeria.
    Batah R; Loucif L; Olaitan AO; Boutefnouchet N; Allag H; Rolain JM
    Microb Drug Resist; 2015 Aug; 21(4):470-6. PubMed ID: 25884511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of a DNA probe and PCR to examine the distribution of the aac(6')-Ic gene in Serratia marcescens and other gram-negative bacteria.
    Snelling AM; Hawkey PM; Heritage J; Downey P; Bennett PM; Holmes B
    J Antimicrob Chemother; 1993 Jun; 31(6):841-54. PubMed ID: 8360124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].
    Sakai S; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):467-84. PubMed ID: 6353020
    [No Abstract]   [Full Text] [Related]  

  • 25. Serratia marcescens.
    Hejazi A; Falkiner FR
    J Med Microbiol; 1997 Nov; 46(11):903-12. PubMed ID: 9368530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism of aminoglycosides and carbenicillin against resistant strains of Serratia marcescens.
    Lin MY; Tuazon CU; Sheagren JN
    J Antimicrob Chemother; 1979 Jan; 5(1):37-44. PubMed ID: 368005
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
    Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
    Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug resistance in Serratia marcescens and cloning of genes responsible for the resistance.
    Chen J; Lee EW; Kuroda T; Mizushima T; Tsuchiya T
    Biol Pharm Bull; 2003 Mar; 26(3):391-3. PubMed ID: 12612456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined effects of micronomicin and latamoxefi in vitro synergistic activities].
    Kurimoto T; Okachi R
    Jpn J Antibiot; 1983 Jul; 36(7):1599-603. PubMed ID: 6418932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.
    Sanders CC; Watanakunakorn C
    J Infect Dis; 1986 Mar; 153(3):617-9. PubMed ID: 3512733
    [No Abstract]   [Full Text] [Related]  

  • 31. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New inactivating enzyme of aminoglycoside antibiotics produced by genes on R-plasmid of Serratia spp. and nosocomial infection].
    Hayashi I; Onuma K; Morohoshi T
    Kansenshogaku Zasshi; 1991 Apr; 65(4):465-71. PubMed ID: 2071963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmid prevalence in antibiotic resistant Serratia marcescens.
    Llanes C; Michel-Briand Y; Bailly C; Grimont F
    J Chemother; 1989 Jul; 1(4 Suppl):311-2. PubMed ID: 16312416
    [No Abstract]   [Full Text] [Related]  

  • 34. Chromosomal origin of acetyltransferase AAC(6') specifying amikacin resistance in Serratia marcescens.
    Gómez-Lus R; Rivera MJ; Bobey D; Martín C; Navarro M
    Microbiologia; 1987 Oct; 3(3):185-94. PubMed ID: 3077328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic resistance in Serratia marcescens.
    Sleigh JD
    Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1651-3. PubMed ID: 6416536
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression analysis of the SdeAB multidrug efflux pump in antibiotic-resistant clinical isolates of Serratia marcescens.
    Dalvi SD; Worobec EA
    Indian J Med Microbiol; 2012; 30(3):302-7. PubMed ID: 22885196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical characteristics and antibiotic susceptibilities of Serratia marcescens isolated from clinical specimens.
    Chong Y; Yi KN; Lee SY
    Yonsei Med J; 1978; 19(1):32-8. PubMed ID: 382648
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of the Serratia marcescens SdeCDE multidrug efflux pump studied via gene knockout mutagenesis.
    Begic S; Worobec EA
    Can J Microbiol; 2008 May; 54(5):411-6. PubMed ID: 18449226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of aminoglycoside usage on susceptibilities.
    Flournoy DJ
    Chemotherapy; 1985; 31(3):178-80. PubMed ID: 3922684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.